谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Abstract PO3-19-09: SERENA-1: Results from a Phase 1 study (Parts I/J) testing the next-generation oral selective estrogen receptor degrader (SERD) camizestrant (AZD9833) in combination with capivasertib in women with ER+, HER2 advanced breast cancer

Christos Vaklavas,Mafalda Oliveira,Anne Armstrong,Irene Moreno,Chris Twelves,Ivan Victoria Ruiz,Begoña Bermejo,Maxine Ajimi,Tim Brier,Carmela Ciardullo,Lisa Gibbons,Itziar Irurzun-Arana,Tony Jack,Teresa Klinowska,Justin Lindemann,Alastair Mathewson,Christopher Morrow,Andy Sykes,Richard Baird

Cancer Research（2024）

引用 0|浏览37
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要